Menu
Haug Partners is pleased to announce that the first installment of our new Life Sciences CLE Program took place on February 20, 2025 and was a great success. Hosted by Partners Wan Chieh (Jenny) Lee and Kaitlin Farrell, panelists revisited the Supreme Court’s 2023 decision in Amgen v. Sanofi. The discussion included how the enablement standard has been applied post-Amgen, the impact of Amgen, and potential strategies for navigating the enablement requirement from drafting to litigation.
We’d like to thank everyone for attending and look forward to announcing our next installment. To find out more about the Life Sciences CLE program and to stay up to date for our newest webinar, please click here.